GMP-based CD133(+) cells isolation maintains progenitor angiogenic properties and enhances standardization in cardiovascular cell therapy.
Gaipa G, Tilenni M, Straino S, Burba I, Zaccagnini G, Belotti D, Biagi E, Valentini M, Perseghin P, Parma M, Campli CD, Biondi A, Capogrossi MC, Pompilio G, Pesce M.
Gaipa G, et al. Among authors: pesce m.
J Cell Mol Med. 2010 Jun;14(6B):1619-34. doi: 10.1111/j.1582-4934.2009.00854.x. Epub 2009 Jul 20.
J Cell Mol Med. 2010.
PMID: 19627397
Free PMC article.